Deciphering hepatocellular carcinoma through metabolomics: from biomarker discovery to therapy evaluation

References

• PatelMShariffMILadepNGHepatocellular carcinoma: diagnostics and screeningJ Eval Clin Pract201218233534221114800
   PubMed Web of Science ®Google Scholar
• OhataKHamasakiKToriyamaKIshikawaHNakaoKEguchiKHigh viral load is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis B virus infectionJ Gastroenterol Hepatol200419667067515151623
   PubMed Web of Science ®Google Scholar
• BoschFXRibesJDiazMCleriesRPrimary liver cancer: worldwide incidence and trendsGastroenterology20041275 Suppl 1S5S1615508102
   PubMed Web of Science ®Google Scholar
• MorganTRMandayamSJamalMMAlcohol and hepatocellular carcinomaGastroenterology20041275 Suppl 1S87S9615508108
   PubMed Web of Science ®Google Scholar
• TsaiJFChuangLYJengJEBetel quid chewing as a risk factor for hepatocellular carcinoma: a case-control studyBr J Cancer200184570971311237396
   PubMed Web of Science ®Google Scholar
• GroopmanJDSchollPWangJSEpidemiology of human aflatoxin exposures and their relationship to liver cancerProg Clin Biol Res19963952112228895991
   PubMedGoogle Scholar
• RegimbeauJMColombatMMognolPObesity and diabetes as a risk factor for hepatocellular carcinomaLiver Transpl2004102 Suppl 1S69S73
   PubMedGoogle Scholar
• JustesenPFengerCHøilund-CarlsenPFHepatocellulært karcinom og andre levertumorer [Hepatocellular carcinoma and other liver tumors]Ugeskr Laeger2006168191876 Danish16756814
   PubMedGoogle Scholar
• TaketaKα-Fetoprotein: reevaluation in hepatologyHepatology1990126142014321701754
   PubMed Web of Science ®Google Scholar
• WishartDSTzurDKnoxCHMDB: the Human Metabolome DatabaseNucleic Acids Res200735DatabaseD521D52617202168
   PubMedGoogle Scholar
• GantiSWeissRHUrine metabolomics for kidney cancer detection and biomarker discoveryUrol Oncol201129555155721930086
   PubMed Web of Science ®Google Scholar
• ZhangASunHWangPHanYWangXRecent and potential developments of biofluid analyses in metabolomicsJ Proteomics20127541079108822079244
   PubMed Web of Science ®Google Scholar
• CatchpoleGSBeckmannMEnotDPHierarchical metabolomics demonstrates substantial compositional similarity between genetically modified and conventional potato cropsProc Natl Acad Sci U S A200510240144581446216186495
   PubMed Web of Science ®Google Scholar
• ArmitageEGSouthamADMonitoring cancer prognosis, diagnosis and treatment efficacy using metabolomics and lipidomicsMetabolomics20161214627616976
   PubMed Web of Science ®Google Scholar
• Kaddurah-DaoukRWeinshilboumRMetabolomic signatures for drug response phenotypes: pharmacometabolomics enables precision medicineClin Pharmacol Ther2015981717525871646
   PubMed Web of Science ®Google Scholar
• LiuCAlessandroAXiaYMetabolomic approach in probing drug candidatesCurr Top Med Chem201717151741174927848895
   PubMed Web of Science ®Google Scholar
• WardPSThompsonCBMetabolic reprogramming: a cancer hallmark even Warburg did not anticipateCancer Cell201221329730822439925
   PubMed Web of Science ®Google Scholar
• SerkovaNJSpratlinJLEckhardtSGNMR-based metabolomics: translational application and treatment of cancerCurr Opin Mol Ther20079657258518041668
   PubMed Web of Science ®Google Scholar
• WangXZhangASunHPower of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinomaHepatology20135752072207723150189
   PubMed Web of Science ®Google Scholar
• ChaiteerakijRAddissieBDRobertsLRUpdate on biomarkers of hepatocellular carcinomaClin Gastroenterol Hepatol201513223724524275343
   PubMed Web of Science ®Google Scholar
• KimhoferTFyeHTaylor-RobinsonSThurszMHolmesEProteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive reviewBr J Cancer201511271141115625826224
   PubMed Web of Science ®Google Scholar
• FitianAICabreraRDisease monitoring of hepatocellular carcinoma through metabolomicsWorld J Hepatol20179111728105254
   PubMedGoogle Scholar
• TongAWuLLinQProteomic analysis of cellular protein alterations using a hepatitis B virus-producing cellular modelProteomics20088102012202318491315
   PubMed Web of Science ®Google Scholar
• YangFYanSHeYExpression of hepatitis B virus proteins in transgenic mice alters lipid metabolism and induces oxidative stress in the liverJ Hepatol2008481121918037187
   PubMed Web of Science ®Google Scholar
• LiHZhuWZhangLThe metabolic responses to hepatitis B virus infection shed new light on pathogenesis and targets for treatmentSci Rep20155842125672227
   PubMed Web of Science ®Google Scholar
• NaTYShinYKRohKJLiver X receptor mediates hepatitis B virus X protein-induced lipogenesis in hepatitis B virus-associated hepatocellular carcinomaHepatology20094941122113119105208
   PubMed Web of Science ®Google Scholar
• YueDZhangYWChengLLHepatitis B virus X protein (HBx)-induced abnormalities of nucleic acid metabolism revealed by 1H-NMR-based metabonomicsSci Rep201662443027075403
   PubMed Web of Science ®Google Scholar
• DaiYCrosMPPontoizeauCElena-HermannBBonnGKHainautPDownregulation of transcription factor E4F1 in hepatocarcinoma cells: HBV-dependent effects on autophagy, proliferation and metabolismCarcinogenesis201435363565024163401
   PubMed Web of Science ®Google Scholar
• XieQFanFWeiWMulti-omics analyses reveal metabolic alterations regulated by hepatitis B virus core protein in hepatocellular carcinoma cellsSci Rep201774108928112229
   PubMed Web of Science ®Google Scholar
• MinHKSookoianSPirolaCJChengJMirshahiFSanyalAJMetabolic profiling reveals that PNPLA3 induces widespread effects on metabolism beyond triacylglycerol remodeling in Huh-7 hepatoma cellsAm J Physiol Gastrointest Liver Physiol20143071G66G7624763554
   PubMed Web of Science ®Google Scholar
• FangMDewaeleSZhaoYPSerum N-glycome biomarker for monitoring development of DENA-induced hepatocellular carcinoma in ratMol Cancer2010921520704698
   PubMed Web of Science ®Google Scholar
• HongEJLevasseurMPDufourCRPerryMCGiguereVLoss of estrogen-related receptor α promotes hepatocarcinogenesis development via metabolic and inflammatory disturbancesProc Natl Acad Sci U S A201311044179751798024127579
   PubMed Web of Science ®Google Scholar
• TanYYinPTangLMetabolomics study of stepwise hepatocarcinogenesis from the model rats to patients: potential biomarkers effective for small hepatocellular carcinoma diagnosisMol Cell Proteomics2012112M111.010694
   PubMed Web of Science ®Google Scholar
• ZengJHuangXZhouLMetabolomics identifies biomarker pattern for early diagnosis of hepatocellular carcinoma: from diethylnitrosamine treated rats to patientsSci Rep201551610126526930
   PubMed Web of Science ®Google Scholar
• HuangXZengJZhouLHuCYinPLinXA new strategy for analyzing time-series data using dynamic networks: identifying prospective biomarkers of hepatocellular carcinomaSci Rep201663244827578360
   PubMed Web of Science ®Google Scholar
• LiZFWangJHuangCGas chromatography/time-of-flight mass spectrometry-based metabonomics of hepatocarcinoma in rats with lung metastasis: elucidation of the metabolic characteristics of hepatocarcinoma at formation and metastasisRapid Commun Mass Spectrom201024182765277520814984
   PubMed Web of Science ®Google Scholar
• WangJZhangSLiZ1H-NMR-based metabolomics of tumor tissue for the metabolic characterization of rat hepatocellular carcinoma formation and metastasisTumour Biol201132122323120890798
   PubMedGoogle Scholar
• TengCFHsiehWCYangCWA biphasic response pattern of lipid metabolomics in the stage progression of hepatitis B virus X tumorigenesisMol Carcinog201655110511425594851
   PubMed Web of Science ®Google Scholar
• FanTRongZDongJMetabolomic and transcriptomic profiling of hepatocellular carcinomas in Hras12V transgenic miceCancer Med20176102370238428941178
   PubMed Web of Science ®Google Scholar
• LiSLiuHJinYLinSCaiZJiangYMetabolomics study of alcohol-induced liver injury and hepatocellular carcinoma xenografts in miceJ Chromatogr B Analyt Technol Biomed Life Sci20118792423692375
   PubMed Web of Science ®Google Scholar
• AssiNFagesAVineisPA statistical framework to model the meeting-in-the-middle principle using metabolomic data: application to hepatocellular carcinoma in the EPIC studyMutagenesis201530674375326130468
   PubMed Web of Science ®Google Scholar
• FagesADuarte-SallesTStepienMMetabolomic profiles of hepatocellular carcinoma in a European prospective cohortBMC Med20151324226399231
   PubMed Web of Science ®Google Scholar
• ChenFXueJZhouLWuSChenZIdentification of serum biomarkers of hepatocarcinoma through liquid chromatography/mass spectrometry-based metabonomic methodAnal Bioanal Chem201140161899190421833635
   PubMed Web of Science ®Google Scholar
• ChenSKongHLuXPseudotargeted metabolomics method and its application in serum biomarker discovery for hepatocellular carcinoma based on ultra high-performance liquid chromatography/triple quadrupole mass spectrometryAnal Chem201385178326833323889541
   PubMed Web of Science ®Google Scholar
• ZengZLiuXDaiWIon fusion of high-resolution LC-MS-based metabolomics data to discover more reliable biomarkersAnal Chem20148683793380024611595
   PubMed Web of Science ®Google Scholar
• LiangQLiuHWangCLiBPhenotypic characterization analysis of human hepatocarcinoma by urine metabolomics approachSci Rep201661976326805550
   PubMed Web of Science ®Google Scholar
• ZhangASunHYanGHanYYeYWangXUrinary metabolic profiling identifies a key role for glycocholic acid in human liver cancer by ultra-performance liquid-chromatography coupled with high-definition mass spectrometryClin Chim Acta2013418869023313056
   PubMed Web of Science ®Google Scholar
• ChenTXieGWangXSerum and urine metabolite profiling reveals potential biomarkers of human hepatocellular carcinomaMol Cell Proteomics2011107M110.004945
   PubMed Web of Science ®Google Scholar
• NahonPAmathieuRTribaMNIdentification of serum proton NMR metabolomic fingerprints associated with hepatocellular carcinoma in patients with alcoholic cirrhosisClin Cancer Res201218246714672223136190
   PubMed Web of Science ®Google Scholar
• RessomHWXiaoJFTuliLUtilization of metabolomics to identify serum biomarkers for hepatocellular carcinoma in patients with liver cirrhosisAnal Chim Acta20127439010022882828
   PubMed Web of Science ®Google Scholar
• XiaoJFVargheseRSZhouBLC-MS based serum metabolomics for identification of hepatocellular carcinoma biomarkers in Egyptian cohortJ Proteome Res201211125914592323078175
   PubMed Web of Science ®Google Scholar
• LiuYHongZTanGNMR and LC-MS-based global metabolomics to identify serum biomarkers differentiating hepatocellular carcinoma from liver cirrhosisInt J Cancer2014135365866824382646
   PubMed Web of Science ®Google Scholar
• ZengJYinPTanYMetabolomics study of hepatocellular carcinoma: discovery and validation of serum potential biomarkers by using capillary electrophoresis-mass spectrometryJ Proteome Res20141373420343124853826
   PubMed Web of Science ®Google Scholar
• FitianAINelsonDRLiuCXuYAraratMCabreraRIntegrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC-MS and UPLC-MS-MSLiver Int20143491428144424661807
   PubMed Web of Science ®Google Scholar
• RanjbarMRLuoYDi PotoCGC-MS based plasma metabolomics for identification of candidate biomarkers for hepatocellular carcinoma in Egyptian cohortPLoS One2015106e012729926030804
   PubMed Web of Science ®Google Scholar
• Di PotoCFerrariniAZhaoYMetabolomic characterization of hepatocellular carcinoma in patients with liver cirrhosis for biomarker discoveryCancer Epidemiol Biomarkers Prev201726567568327913395
   PubMed Web of Science ®Google Scholar
• SanabriaJRKombuRSZhangGFGlutathione species and metabolomic prints in subjects with liver disease as biological markers for the detection of hepatocellular carcinomaHPB (Oxford)2016181297999028340971
   PubMed Web of Science ®Google Scholar
• WangBChenDChenYMetabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometryJ Proteome Res20121121217122722200553
   PubMed Web of Science ®Google Scholar
• ShaoYZhuBZhengRDevelopment of urinary pseudotargeted LC-MS-based metabolomics method and its application in hepatocellular carcinoma biomarker discoveryJ Proteome Res201514290691625483141
   PubMed Web of Science ®Google Scholar
• ShariffMIGomaaAICoxIJUrinary metabolic biomarkers of hepatocellular carcinoma in an Egyptian population: a validation studyJ Proteome Res20111041828183621275434
   PubMed Web of Science ®Google Scholar
• OsmanDAliOObadaMEl-MezayenHEl-SaidHChromatographic determination of some biomarkers of liver cirrhosis and hepatocellular carcinoma in Egyptian patientsBiomed Chromatogr2017316e3893
   Web of Science ®Google Scholar
• DaiWYinPChenPStudy of urinary steroid hormone disorders: difference between hepatocellular carcinoma in early stage and cirrhosisAnal Bioanal Chem2014406184325433524817358
   PubMed Web of Science ®Google Scholar
• CaoHHuangHXuWFecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography-mass spectrometryAnal Chim Acta20116911–2687521458633
   PubMed Web of Science ®Google Scholar
• PattersonADMaurhoferOBeyogluDAberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profilingCancer Res201171216590660021900402
   PubMed Web of Science ®Google Scholar
• ZhouLDingLYinPSerum metabolic profiling study of hepatocellular carcinoma infected with hepatitis B or hepatitis C virus by using liquid chromatography-mass spectrometryJ Proteome Res201211115433544222946841
   PubMed Web of Science ®Google Scholar
• TianSChangHHWangCJiangJWangXNiuJMulti-TGDR, a multi-class regularization method, identifies the metabolic profiles of hepatocellular carcinoma and cirrhosis infected with hepatitis B or hepatitis C virusBMC Bioinformatics2014159724707821
   PubMed Web of Science ®Google Scholar
• BowersJHughesESkillNMaluccioMRafteryDDetection of hepatocellular carcinoma in hepatitis C patients: biomarker discovery by LC-MSJ Chromatogr B Analyt Technol Biomed Life Sci2014966154162
   PubMed Web of Science ®Google Scholar
• WeiSSuryaniYGowdaGASkillNMaluccioMRafteryDDifferentiating hepatocellular carcinoma from hepatitis C using metabolite profilingMetabolites20122470171624957758
   PubMedGoogle Scholar
• BaniasadiHGowdaGAGuHTargeted metabolic profiling of hepatocellular carcinoma and hepatitis C using LC-MS/MSElectrophoresis201334192910291723856972
   PubMed Web of Science ®Google Scholar
• GaoRChengJFanCSerum metabolomics to identify the liver disease-specific biomarkers for the progression of hepatitis to hepatocellular carcinomaSci Rep201551817526658617
   PubMed Web of Science ®Google Scholar
• GongZGZhaoWZhangJMetabolomics and eicosanoid analysis identified serum biomarkers for distinguishing hepatocellular carcinoma from hepatitis B virus-related cirrhosisOncotarget2017838638906390028969038
   PubMedGoogle Scholar
• LinXGaoJZhouLYinPXuGA modified k-TSP algorithm and its application in LC-MS-based metabolomics study of hepatocellular carcinoma and chronic liver diseasesJ Chromatogr B Analyt Technol Biomed Life Sci2014966100108
   PubMed Web of Science ®Google Scholar
• ZhouLWangQYinPSerum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseasesAnal Bioanal Chem2012403120321322349331
   PubMed Web of Science ®Google Scholar
• SogaTSugimotoMHonmaMSerum metabolomics reveals γ-glutamyl dipeptides as biomarkers for discrimination among different forms of liver diseaseJ Hepatol201155489690521334394
   PubMed Web of Science ®Google Scholar
• HuangQTanYYinPMetabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomicsCancer Res201373164992500223824744
   PubMed Web of Science ®Google Scholar
• LiuSYZhangRLKangHFanZJDuZHuman liver tissue metabolic profiling research on hepatitis B virus-related hepatocellular carcinomaWorld J Gastroenterol201319223423343223801834
   PubMed Web of Science ®Google Scholar
• BudhuARoesslerSZhaoXIntegrated metabolite and gene expression profiles identify lipid biomarkers associated with progression of hepatocellular carcinoma and patient outcomesGastroenterology2013144510661075 e106123376425
   PubMed Web of Science ®Google Scholar
• BeyoğluDImbeaudSMaurhoferOTissue metabolomics of hepatocellular carcinoma: tumor energy metabolism and the role of transcriptomic classificationHepatology201358122923823463346
   PubMed Web of Science ®Google Scholar
• MurakamiYKuboSTamoriAComprehensive analysis of transcriptome and metabolome analysis in intrahepatic cholangiocarcinoma and hepatocellular carcinomaSci Rep201551629426538415
   PubMed Web of Science ®Google Scholar
• DarpolorMMBasuSSWorthAThe aspartate metabolism pathway is differentiable in human hepatocellular carcinoma: transcriptomics and 13C-isotope based metabolomicsNMR Biomed201427438138924497316
   PubMed Web of Science ®Google Scholar
• SpratlinJLPittsTMKulikowskiGNSynergistic activity of histone deacetylase and proteasome inhibition against pancreatic and hepatocellular cancer cell linesAnticancer Res20113141093110321508352
   PubMed Web of Science ®Google Scholar
• ZhengJFLuJWangXZGuoWHZhangJXComparative metabolomic profiling of hepatocellular carcinoma cells treated with sorafenib monotherapy vs. sorafenib-everolimus combination therapyMed Sci Monit2015211781179126092946
   PubMed Web of Science ®Google Scholar
• AsgharUMeyerTAre there opportunities for chemotherapy in the treatment of hepatocellular cancer?J Hepatol201256368669521971559
   PubMed Web of Science ®Google Scholar
• IwaoCShidojiYUpregulation of energy metabolism-related, p53-target TIGAR and SCO2 in HuH-7 cells with p53 mutation by geranylgeranoic acid treatmentBiomed Res201536637138126700591
   PubMed Web of Science ®Google Scholar
• ChengMLShiaoMSChiuDTWengSFTangHYHoHYBiochemical disorders associated with antiproliferative effect of dehydroepian-drosterone in hepatoma cells as revealed by LC-based metabolomicsBiochem Pharmacol201182111549156121843511
   PubMed Web of Science ®Google Scholar
• IkutaNChikamotoKAsanoYTime course effect of R-α-lipoic acid on cellular metabolomics in cultured hepatoma cellsJ Med Food201720321122228296595
   PubMed Web of Science ®Google Scholar
• QinXYWeiFTanokuraMThe effect of acyclic retinoid on the metabolomic profiles of hepatocytes and hepatocellular carcinoma cellsPLoS One2013812e8286024376596
   PubMed Web of Science ®Google Scholar
• NoguchiYYoungJDAlemanJOHansenMEKelleherJKStephanopoulosGTracking cellular metabolomics in lipoapoptosis- and steatosis-developing liver cellsMol Biosyst2011751409141921327189
   PubMedGoogle Scholar
• KumarPSinghAKRajV6,7-Dimethoxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid attenuates hepatocellular carcinoma in rats with NMR-based metabolic perturbationsFuture Sci OA201733FSO20228884001
   PubMed Web of Science ®Google Scholar
• LiFLiXMiaoYUHPLC-MS-based metabolomics analysis on mice bearing neoplasm (H22) for hispidulinJ Pharm Biomed Anal201612531031827077962
   PubMed Web of Science ®Google Scholar
• MaTFanBYZhangCMetabonomics applied in exploring the antitumour mechanism of physapubenolide on hepatocellular carcinoma cells by targeting glycolysis through the Akt-p53 pathwaySci Rep201662992627416811
   PubMed Web of Science ®Google Scholar
• QinXYTatsukawaHHitomiKMetabolome analyses uncovered a novel inhibitory effect of acyclic retinoid on aberrant lipogenesis in a mouse diethylnitrosamine-induced hepatic tumorigenesis modelCancer Prev Res (Phila)20169320521426744170
   PubMed Web of Science ®Google Scholar
• BaoYWangSYangXLiTXiaYMengXMetabolomic study of the intervention effects of shuihonghuazi formula, a traditional Chinese medicinal formulae, on hepatocellular carcinoma (HCC) rats using performance HPLC/ESI-TOF-MSJ Ethnopharmacol201719846847828108381
   PubMed Web of Science ®Google Scholar
• ZhouLLiaoYYinPMetabolic profiling study of early and late recurrence of hepatocellular carcinoma based on liquid chromatography-mass spectrometryJ Chromatogr B Analyt Technol Biomed Life Sci2014966163170
   PubMed Web of Science ®Google Scholar
• YeGZhuBYaoZAnalysis of urinary metabolic signatures of early hepatocellular carcinoma recurrence after surgical removal using gas chromatography-mass spectrometryJ Proteome Res20121184361437222768978
   PubMed Web of Science ®Google Scholar
• GoossensCNahonPle MoyecLSequential serum metabolomic profiling after radiofrequency ablation of hepatocellular carcinoma reveals different response patterns according to etiologyJ Proteome Res20161551446145427015127
   PubMed Web of Science ®Google Scholar
• ChenYZhouJLiJFengJChenZWangXPlasma metabolomic analysis of human hepatocellular carcinoma: diagnostic and therapeutic studyOncotarget2016730473324734227322079
   PubMedGoogle Scholar
• SpratlinJLSerkovaNJEckhardtSGClinical applications of metabolomics in oncology: a reviewClin Cancer Res200915243144019147747
   PubMed Web of Science ®Google Scholar
• GikaHGTheodoridisGAPlumbRSWilsonIDCurrent practice of liquid chromatography-mass spectrometry in metabolomics and metabonomicsJ Pharm Biomed Anal201487122523916607
   PubMed Web of Science ®Google Scholar
• GrebeSKSinghRJLC-MS/MS in the clinical laboratory: where to from here?Clin Biochem Rev201132153121451775
   PubMedGoogle Scholar
• VermeerschKAStyczynskiMPApplications of metabolomics in cancer researchJ Carcinog201312923858297
   PubMedGoogle Scholar
• HwangVJWeissRHMetabolomic profiling for early cancer detection: current status and future prospectsExpert Opin Drug Metab Toxicol Epub2016913
   Web of Science ®Google Scholar
• GoodacreRVaidyanathanSDunnWBHarriganGGKellDBMetabolomics by numbers: acquiring and understanding global metabolite dataTrends Biotechnol200422524525215109811
   PubMed Web of Science ®Google Scholar
• NicholsonJKLindonJCSystems biology: metabonomicsNature200845572161054105618948945
   PubMed Web of Science ®Google Scholar
• EverettJRPharmacometabonomics in humans: a new tool for personalized medicinePharmacogenomics201516773775425929853
   PubMed Web of Science ®Google Scholar